[PSY-1] Molecular targeted therapy of acute myeloid leukemia
Dr. Hartmut Döhner is Professor of Medicine, since 1999 Medical Director of the Department of Internal Medicine III (Hematology, Oncology, Palliative Medicine, Rheumatology and Infectious Diseases) at Ulm University and since 2006 founding Director of the Comprehensive Cancer Center Ulm.
Dr. Döhner studied medicine at the Universities of Regensburg, Freiburg and Montpellier (France). He received his training in Hematology and Medical Oncology at the University of Heidelberg. Between 1988 and 1990 he spent a two-year period as a post-doctoral associate in the Department of Medicine, Division of Oncology (Prof. Clara Bloomfield) and the Department of Laboratory Medicine and Pathology, Division of Medical Genetics (Prof. Diane Arthur), University of Minnesota, Minneapolis, USA.
Dr. Döhner’s main research interests are the identification, characterization and clinical diagnosis of genetic changes in hematologic malignancies, including acute and chronic leukemias. Dr. Döhner is chairman of the German-Austrian AML Study Group (AMLSG). He is Coordinating Investigator of the Collaborative Research Center (SFB 1074) ‘Experimental models and clinical translation in leukemia’ funded by the German Research Foundation (DFG). His Department harbors the genetic reference laboratory for several multicenter trial groups, including the AMLSG.
Dr. Döhner has received many awards, including the 2014 José Carreras Award of the European Hematology Association.
Dr. Döhner studied medicine at the Universities of Regensburg, Freiburg and Montpellier (France). He received his training in Hematology and Medical Oncology at the University of Heidelberg. Between 1988 and 1990 he spent a two-year period as a post-doctoral associate in the Department of Medicine, Division of Oncology (Prof. Clara Bloomfield) and the Department of Laboratory Medicine and Pathology, Division of Medical Genetics (Prof. Diane Arthur), University of Minnesota, Minneapolis, USA.
Dr. Döhner’s main research interests are the identification, characterization and clinical diagnosis of genetic changes in hematologic malignancies, including acute and chronic leukemias. Dr. Döhner is chairman of the German-Austrian AML Study Group (AMLSG). He is Coordinating Investigator of the Collaborative Research Center (SFB 1074) ‘Experimental models and clinical translation in leukemia’ funded by the German Research Foundation (DFG). His Department harbors the genetic reference laboratory for several multicenter trial groups, including the AMLSG.
Dr. Döhner has received many awards, including the 2014 José Carreras Award of the European Hematology Association.
Abstract password authentication.
Password is written on a program and abstract book.